Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$9,214,187
-$1,486,005 QoQ
Shares Held
382,649
+0.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#441
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Compagnie Lombard Odier SCmA holds $723,906,825 across 10 Drug Manufacturers - General names. PFE ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
258,737 | $310,336,944 | |
| 2 | MRK |
Merck & Co., Inc.
|
790,796 | $101,617,285 | |
| 3 | JNJ |
Johnson & Johnson
|
375,199 | $95,289,289 | |
| 4 | AZN |
Astrazeneca PLC
|
395,004 | $74,900,656 | |
| 5 | ABBV |
AbbVie Inc.
|
276,074 | $69,471,261 | |
| 6 | AMGN |
Amgen Inc
|
171,214 | $62,000,013 | |
| 7 | PFE |
Pfizer Inc
This page
|
382,649 | $9,214,187 | |
| 8 | NVO |
Novo Nordisk A S
|
20,029 | $960,190 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,214,187 | 382,649 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $10,700,192 | 381,061 | Shares | Defined | 2026-04-15 | |
| 2025-12-31 | $9,617,002 | 386,225 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $9,674,577 | 379,693 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $9,512,210 | 392,418 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $9,351,371 | 369,036 | Shares | Defined | 2025-04-16 | |
| 2024-12-31 | $9,790,524 | 369,036 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $11,162,331 | 385,706 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $12,793,183 | 457,226 | Shares | Defined | 2024-07-18 | |
| 2024-03-31 | $10,525,741 | 379,306 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $7,216,357 | 250,655 | Shares | Defined | 2024-01-16 | |
| 2023-09-30 | $2,037,699 | 61,432 | Shares | Defined | 2023-10-23 | |
| 2023-06-30 | $3,415,347 | 93,112 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $2,780,315 | 68,145 | Shares | Defined | 2023-05-01 | |
| 2022-12-31 | $3,740,826 | 73,006 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,058,955 | 69,903 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $3,778,524 | 72,068 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $3,871,773 | 74,788 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $5,349,397 | 90,591 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $3,959,801 | 92,067 | Shares | Defined | 2021-10-28 | |
| 2021-06-30 | $4,003,834 | 102,243 | Shares | Defined | 2021-07-15 | |
| 2021-03-31 | $3,240,156 | 89,433 | Shares | Defined | 2021-04-23 | |
| 2020-12-31 | $4,476,831 | 121,620 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,843,620 | 50,235 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,260,421 | 38,545 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,421,305 | 43,545 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||